Loading stock data…
YCBD
$0.80+0.01 (+1.48%)
Pre-Market$0.83+0.03 (+4.25%)· Last close May 13
cbdMD, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
cbdMD, Inc. in the Healthcare sector is trading at $0.80. Wall Street consensus targets $2.00 (1 analysts), implying a +151.3% move over the next 12 months. The stock is currently near its 52-week low of $0.47, remaining 9.6% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +151.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 22) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$0.80
Potential Upside
707%
Whystock Fair Value$6.42
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gel...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.76M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
1.55
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.10
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-25.97%
Volume
Today's trading volume
252,285
Recent News
cbdMD, Inc. Q1 2026 Earnings Call Summary
Moby summary of cbdMD, Inc.'s Q1 2026 earnings call
cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ...
cbdMD Inc (YCBD) reports significant financial management improvements and strategic acquisitions, despite facing sales and regulatory challenges.
cbdMD Inc (YCBD) Q4 2025 Earnings Call Highlights: Strategic Growth Amidst Regulatory Challenges
cbdMD Inc (YCBD) reports improved financials and strategic expansion plans, despite a slight dip in annual sales and ongoing regulatory hurdles.
Correction: Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session
(Corrects the third paragraph to note the personal income and outlays report being rescheduled.)
Wall Street Set to Open Little Changed as Investors Await Home Sales, Consumer Sentiment Data
US stocks look set to open little changed Friday's trading session as investors look ahead to econom